Holen Sie sich die Stockscreener-App
131.23
2.43%
3.11
Handel nachbörslich:
128.80
-2.43
-1.85%
Neurocrine Biosciences Inc Aktie (NBIX) Neueste Nachrichten
Neurocrine to buy Soleno Therapeutics for $53/share in cash - MSN
Soleno Therapeutics rallies on report of $2.5B Neurocrine buyout talks - MSN
Neurocrine-Soleno deal garners Wall Street praise — analyst applauds business development acumen - MSN
Neurocrine, Soleno HSR waiting period expired April 27 - MLex
Neurocrine Biosciences-Soleno Therapeutics HSR waiting period expired April 27 - MLex
Neurocrine (NASDAQ: SLNO) to acquire Soleno for $53.00 per share after HSR clearance - Stock Titan
Neurocrine to buy Soleno Therapeutics for $2.9 billion - MSN
Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unlocking a 45% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews
Soleno Therapeutics stock rallies 56.4% in a week: Here's why - msn.com
Wall Street analysts think Neurocrine (NBIX) could surge 38.79%: Read this before placing a bet - MSN
A Look At Neurocrine Biosciences (NBIX) Valuation After CRENESSITY Phase 3 CAHtalyst Adult Results - simplywall.st
Neurocrine to buy Soleno for treatment for rare disease that causes relentless hunger - MSN
Munich Reinsurance Co Stock Corp in Munich Buys 10,168 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine nears $2.5B-plus deal to buy Soleno TherapeuticsFT - MSN
CRENESSITY Phase 3 Data on Lower Steroid Doses Could Be A Game Changer For Neurocrine Biosciences (NBIX) - simplywall.st
Neurocrine Biosciences (NASDAQ:NBIX) Raised to Strong-Buy at Wall Street Zen - MarketBeat
NBIX News | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - ChartMill
Morgan Stanley Maintains Neurocrine Biosciences (NBIX) Overweight Recommendation - MSN
Ruffer LLP Invests $2.48 Million in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Deutetrabenazine Market to Witness Massive Growth by 2033 |Teva - openPR.com
Neurocrine reports sustained glucocorticoid reductions in CAH study By Investing.com - Investing.com India
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine reports sustained glucocorticoid reductions in CAH study - Investing.com
Neurocrine reports sustained dose reductions with CRENESSITY in CAH patients - StreetInsider
Rare adrenal disorder drug helped 7 in 10 adults cut steroid doses - Stock Titan
NBIX Maintained by Leerink Partners -- Price Target Raised to $1 - GuruFocus
How Neurocrine Biosciences Inc. (NBIX) Affects Rotational Strategy Timing - Stock Traders Daily
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $170.00 - MarketBeat
Belpointe Asset Management LLC Acquires Shares of 9,485 Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Why this Bay Area company took a buyout offer that was nearly $2 billion less than an earlier bid - The Business Journals
3 Reasons Growth Investors Will Love Neurocrine (NBIX) - Yahoo Finance
Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $185 - Moomoo
Wall Street Analysts Think Neurocrine (NBIX) Could Surge 38.79%: Read This Before Placing a Bet - Yahoo Finance
NBIX Stock Chart | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - ChartMill
Lobbying Update: $940,000 of NEUROCRINE BIOSCIENCES INC lobbying was just disclosed - Quiver Quantitative
Neurocrine is making a $2.9 billion bet on a new kind of drug - MSN
Neurocrine Biosciences (NASDAQ: SLNO) offers $53.00 per share cash to Soleno - Stock Titan
Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unveiling a 39.92% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
KBC Group NV Has $4.60 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Fortis Capital Advisors LLC Invests $1.35 Million in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
A Look At Neurocrine Biosciences (NBIX) Valuation After New INGREZZA Persistence Data And Options Activity - simplywall.st
NBIX SEC FilingsNeurocrine Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cwm LLC Purchases 11,306 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
A Look at Neurocrine Biosciences Inc (NBIX) After 3.8% Gain -- G - GuruFocus
Neurocrine's Acquisition Impacts Soleno Therapeutics (SLNO) Rati - GuruFocus
How New Real-World INGREZZA Data Versus AUSTEDO XR Will Impact Neurocrine Biosciences (NBIX) Investors - simplywall.st
0.34%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):